Humanin

Overview

Humanin is a 24-amino-acid mitochondrial-derived peptide (MDP) that functions as a powerful cytoprotective and neuroprotective agent. It works by holding back apoptosis through its interactions with the Bax and Bcl-2 proteins and by reducing oxidative stress and inflammation across multiple organ systems.

Editorial verdict

Humanin sits on a genuinely intriguing biology — a peptide encoded within mitochondrial DNA, naturally higher in long-lived people — but the longevity enthusiasm around it runs well ahead of the human evidence. The headline animal results are striking, yet direct human supplementation data is thin, and the citation pool here carries flags (2 retracted, 2 criticised) that warrant a skeptical read. Promising signal, not a proven anti-aging fix.

How it works

Humanin shields cells by inhibiting apoptosis through Bax and IGFBP-3 pathways and by curbing oxidative stress, with benefits reported across neural, cardiovascular, and metabolic tissue. Circulating levels fall with age, which is why longevity enthusiasts frame 'replacement' as a target.

Evidence quality

The grade is A-, weighted across 142 peer-reviewed studies (3 RCTs, 10 observational, 57 animal, 35 in vitro, 37 reviews). Of 142 classified findings, 117 support its protective roles, 21 are mixed, 1 is null, and 3 refute, but the human base is just 3 RCTs, and 2 studies are retracted with 2 more criticised — meaning the supportive tally should be read cautiously.

Who should be cautious

Because human supplementation data is still emerging, anyone treating Humanin as a tested therapy is getting ahead of the science. Its interaction with growth hormone pathways, hinted at by the centenarian data, also deserves caution.

Community sentiment

Across 6 community reports, discussion is sparse, with mentions down 100% year over year. Reported effects are single mentions of longevity, resistance to ApoE4-induced brain pathology, AMPK activation, mitochondrial function, and neuroprotection; common topics are mitochondrial function and the UK Biobank.

Studies cited (summarised)

• An observational study finding that Humanin improves memory in aged mice and that higher natural levels in people track with better cognitive aging.
• An animal study showing Humanin overexpression extends lifespan in C. elegans and improves metabolic and inflammatory markers in middle-aged mice.
• A systematic review outlining Humanin's protective role against neurodegeneration, cardiovascular disease, and metabolic disorders such as diabetes.
• A review detailing how Humanin defends the heart and blood vessels by cutting oxidative stress and preserving mitochondrial function.

Dosage and effectiveness

In research settings the potent HNG analog — roughly 1000-fold more active than native Humanin — is often preferred, typically given by subcutaneous injection on a twice-weekly schedule for healthspan maintenance. Reported strengths include preserving memory and learning in aging models, strong correlation with healthspan and mitochondrial function, and promising vascular protection, though robust human supplementation data is still developing.

Availability

Humanin is sold mainly through peptide supply companies for laboratory and research use; lifestyle measures such as exercise and cold exposure are sometimes discussed as ways to support endogenous levels. It is not FDA-approved for any human medical treatment and remains strictly a research compound.